Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
55%
OVERLAP
BY WEIGHT
38
# OF OVERLAPPING
HOLDINGS
WELS.DE
86
HOLDINGS
45%
ALSO IN XDG3.DE
XDG3.DE
115
HOLDINGS
34%
ALSO IN WELS.DE
SECTOR DRIFT (WELS.DE minus XDG3.DE)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in WELS.DE |
Weight in XDG3.DE |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 11.6% | 4.5% | 4.5% |
 |
ASTRAZENECA PLC | 4.3% | 4.7% | 4.3% |
|
ABBVIE INC | 6.6% | 4.1% | 4.1% |
|
MERCK & CO. INC. | 4.1% | 5.4% | 4.1% |
|
THERMO FISHER SCIENTIFIC INC | 3.7% | 4.7% | 3.7% |
WELS.DE Overweight Relative to XDG3.DE
|
ELI LILLY & CO | 7.1% |
|
UNITEDHEALTH GROUP INC | 5.4% |
 |
ROCHE HOLDING AG-BR | 4.6% |
|
NOVARTIS AG | 3.8% |
|
INTUITIVE SURGICAL INC | 2.8% |
|
ABBVIE INC | 2.5% |
|
CVS CAREMARK CORP | 1.4% |
|
ELEVANCE HEALTH INC | 1.2% |
 |
ESSILOR INTERNATIONAL | 1.2% |
|
CIGNA CORPORATION | 1.0% |
WELS.DE Underweight Relative to XDG3.DE
|
DANAHER CORP | -2.6% |
|
STRYKER CORP | -2.5% |
|
VERTEX PHARMACEUTICALS INC | -2.3% |
 |
NOVO NORDISK A/S-B | -2.1% |
|
BRISTOL-MYERS SQUIBB CO | -2.0% |
|
GILEAD SCIENCES INC | -1.8% |
|
ABBOTT LABORATORIES | -1.7% |
|
SANOFI-AVENTIS | -1.4% |
|
AMGEN INC | -1.3% |
|
MERCK & CO. INC. | -1.3% |